The Pharma Professionals Interview Guide PDF

Download as pdf or txt
Download as pdf or txt
You are on page 1of 48
At a glance
Powered by AI
The key takeaways from the document are the definitions and requirements of standard operating procedures (SOPs) and master production and control records (MPCRs) in the pharmaceutical industry.

SOPs are detailed written instructions for the operations routinely performed in the course of any activities associated with pharmaceutical manufacturing.

The contents of an SOP include the objective/purpose, scope, responsibility, accountability, procedure, list of formats/annexure, abbreviations, and reference.

Page 2 of 48 | The Pharma Professionals Interview Guide

1. What is the definition of SOP?


SOPs are detailed written instructions for the operations routinely performed in the course of any activities
associated with pharmaceutical manufacturing.
Or
A written authorized procedure which gives instructions for performing operations not necessarily specific
to a given product / material, but of a more general nature the equipments preventive maintenance and
cleaning; recall of products; purchasing; cleaning of premises and environmental control; sampling and
inspection etc.
Or
These are guidelines which describe how the activity is to be performed. To achieve uniformity of results
by each individual, it is mandatory to follow these guidelines. SOP is like a “TELL and SHOW” concept.

Tell – means to establish and teach how the activity is to be carried out.
Show – means to provide the documented proof for the activity carried out.

2. What are the contents of the SOP?


Objective/Purpose, Scope, Responsibility, Accountability, Procedure, List of formats/Annexure,
Abbreviations, Reference, Revision History

3. Which information should master document carry on every page not just one of the pages to meet GMP?
Page number, document reference number and authorizing signatures

4. How many SOPs required for equipment and what are those?
Operation, Cleaning, Preventive maintenance/ Calibration, Sampling procedure

5. What is the Batch production and control record (BPCR)?


BPCR are prepared for each intermediate and API and include the complete information relating to the
completion of each significant step in the Batch production.

6. What is the Master production & control record (MPCR)?


To ensure the uniformity from batch to batch, master production instructions for each intermediate and API
are prepared, dated and signed by one person, immediately checked, dated and signed by a person in the
quality unit.
Page 3 of 48 | The Pharma Professionals Interview Guide

7. What are the content of the MPCR?


The name of the intermediate or API being manufactured and an identifying document reference code,
if applicable.
A complete list of raw materials and intermediates designated by names or codes sufficiently specific to
identify any special quality characteristics.
An accurate statement of the quantity or ratio of each raw material or intermediate to be used, including
the unit of measure. Where the quantity is not fixed, the calculation for each batch size or rate of
production should be included. Variations to quantities should be included where they are justified.
The production location and major production equipment to be used.
Detailed production instructions, including the:
 Sequences to be followed.
 Ranges of process parameters to be used.
 Sampling instructions and in-process controls with their acceptance criteria, where appropriate.
 Time limits for completion of individual processing steps and/or the total process, where appropriate.
 Expected yield ranges at appropriate phases of processing or time.
 Where appropriate, special notations and precautions to be followed, or cross-references to these.
The instructions for storage of the intermediate or API to ensure its suitability for use, including the
labeling and packaging materials and special storage conditions with time limits, where appropriate.

8. What is the list SOPs required in QA department?


SOP for SOP, SOP for format preparation, change control, deviation, Non-conformance products, market
complaints, product recall, returned goods, vendor qualification, preparation of BPCR & MPCR, Assigning
of Mfg. date & Expiry date, annual product review, corrective action & preventive action, process
validation, cleaning validation, equipment qualification, glossary of terms, document control, Review of
BPCR & analytical test report, batch numbering system, labeling practice, personnel training, BPCR issue
and retrieval, batch release, self-inspection (internal audit), file numbering system, preparation of
organogram, preparation of COA, specimen signatures, Reprocess & rework of intermediates / API, Job
responsibilities, Technology transfer, measurable quality objectives etc.
9. What is the difference between intermediate, drug substance (API) and drug product?
Intermediate: A material produced during steps of the processing of an API that undergoes further
molecular change or purifications before it become an API (Reference: ICH Q7A).
Drug substance (API): Any substance or mixture of substances intended to be used in the manufacture of
a drug (medicinal) product and that, when used in the production of a drug, becomes an active ingredient of
the drug product. Such substances are intended to furnish pharmacological activity or other direct effect in
the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure and function of
the body (Reference: ICH Q7A).
Drug product: The dosage form in the final immediate packaging intended for marketing.
Page 4 of 48 | The Pharma Professionals Interview Guide

10. What is the clean room?


Clean rooms are defined as especially constructed, environmentally controlled enclosed spaces with respect
to airborne particulates, temperature, humidity, air pressure, air flow patterns, air motion, vibration, noise,
viable (living organisms) and lighting.
Particulate control includes:
 Particulate & microbial contamination.
 Particulate concentration & dispersion.

11. What are the classifications of clean rooms?


Generally clean rooms are classified in to the following types as per different guidelines: Schedule
M: Grade A, Grade B, Grade C, and Grade D.
USFDA (US 209E): Class 1, Class 10, Class 100, Class 1000, Class 10000, and Class 100,000.
WHO 2002: Grade A, Grade B, Grade C, and Grade D.
EU GMP: Grade A, Grade B, Grade C, and Grade D.
ISO 14644-1: ISO-3, ISO-4, ISO-5, ISO-6, ISO-7, ISO-8, and ISO-9.
Britain (BS 5295): Class C, Class D, Class E or F, Class G or H, Class J, and Class K.
Australia (AS 1386): 0.035, 0.35, 3.5, 35, 350, and 3500.
Germany (VDI 2083): 1, 2, 3, 4, 5, and 6.

12. What is the difference between GMP & cGMP?


GMP: GMP is the part of Quality assurance which ensures that products are consistently produced and
controlled to the quality standards appropriate to their intended use and as required by the marketing
authorization.
GMP are aimed primarily at diminishing the risks inherent in any pharmaceutical production. Such risks are
essentially of two types:
 Cross-contamination (in particular of unexpected contamination)
 Mix-ups (confusion)
cGMP: Current Good Manufacturing Practices. This means any procedure / system adopted by the
manufacturer which proves to be necessary and important for identity, strength and purity of a product.

13. What is the difference between Qualification and Validation?


Qualification is equipment / instrument oriented but validation is process oriented.

14. What is the definition of Validation?


Validation is the documented program that provides a high degree of assurance that a specific process,
method or system will consistently produce a result meeting predetermined acceptance criteria.
Page 5 of 48 | The Pharma Professionals Interview Guide

15. What is the definition of Qualification?


Qualification is the action of proving and documenting that any equipment or ancillary systems are properly
installed, work correctly, actually leads the expected results. Qualification is part of validation, but the
individual qualification steps alone do not constitute process validation.

16. What are the types of validation?


Process validation, Analytical method validation, cleaning validation, facility validation, Utility validation
&software validation.

17. Definition of process validation and types of process validation?


Process validation is the documented evidence that the process, operated within established parameters,
can perform effectively and reproducibly to produce an intermediate / API meeting its pre-determined
specifications and quality attributes.
Process validation is three types:
 Prospective process validation
 Concurrent process validation
 Retrospective process validation

18. What is the prospective, concurrent and retrospective validation?


Prospective process validation: Prospective Process validation shall be carried out for all the intermediate
stages and Active Pharmaceutical Ingredients prior to the distribution of a new product. [ICH: GMP, EU:
GMP, PIC/S: GMP]
Concurrent process validation: Any validated process undergoes a change either for the equipment or
addition, deletion of a critical manufacturing process step, scale up or scale down, the same needs to be
validated concurrently.
The validation is carried out only after a change of an existing validated process to support the change made
or involve with the requirements.
Or
A subset of prospective validation in which API batches are released for distribution, based on extensive
testing, before completion of process validation. Once data from additional batches produced under
replicated conditions show uniformity, the process may be considered validated.
Or
Concurrent validation can be conducted when data from replicate production runs are unavailable because
only a limited number of API batches have been produced, API batches are produced infrequently, or API
batches are produced by a validated process that has been modified. [ICH: GMP, EU: GMP, PIC/S: GMP]
Retrospective process validation: Validation of a process for a product already in distribution based upon
accumulated production, testing and control data. [ICH: GMP, EU: GMP, PIC/S:GMP]
Page 6 of 48 | The Pharma Professionals Interview Guide

19. What do you mean by validation protocol and its contents of process validation?
A written plan stating, how validation will be conducted and defining acceptance criteria e.g.: The protocol
for manufacturing process identifies process equipment, critical process parameters, and / or operating
range, product characteristics, sampling, test data to be collected, number of validations runs and acceptance
test results.
Contents:
 Protocol Approval
 Table of contents
 Objective
 Scope
 Responsibility
 Accountability
 Validation team
 Brief manufacturing process (Description, Flow chart, Reaction scheme)
 Selection of batches
 List of equipment used in the manufacturing process
 List of raw materials used in the manufacturing process
 Critical operations with justification
 In-process controls with acceptance criteria
 Sampling & testing plan with frequency
 Stability program
 Data to be complied
 Acceptance criteria
 Intermediate & final products quality &yield.
 Stability specification
 Document review
 Conclusion
 Revalidation criteria

20. What is the definition of the procedure?


A documented description of the operation to be performed, the precautions to be taken, and measures to be
applied directly or indirectly related to the manufacture of an intermediate / API (Reference: ICH Q7A).
Page 7 of 48 | The Pharma Professionals Interview Guide

21. What is the master document?


Master document is a formally authorized source document relating to specifications, and / or manufacturing
/ analytical methods, which is protected from un-authorized access or amendment.
 Documents required describing the quality system requirements in the organization.
 Documents required describing the process or product characteristics.
 Documents required by various regulatory agencies as part of compliance to GMP requirements.
 Documents required for legal/ regulatory supports of the organization to meet the local regulations.
 Any other documents required by government / regulatory agency.

22. What is documentation?


All the written production procedures, instructions and records, quality control procedures and recorded test
results involved in the manufacturing of a medicinal product.

23. What is the Technology Transfer?


In the pharmaceutical industry, “technology transfer” refer to the processes that are needed for successful
progress from drug discovery to product development to clinical trials to full-scale commercialization or it
is the process by which a developer of technology makes its technology available to commercial partner
that will exploit the technology.

To assure the drug quality, it is desire to make sure 5 W’s and 1 H, that is what1, when2, and why3
information should be transferred to where4 and by whom5 and how to transfer, then share knowledge and
information of the technology transfer each other between stake holders related to drug manufacturing.

24. What are the names of different countries of GMP guidelines for manufacturing of API?
WHO GMP - Geneva
ICH Q7A – Europe, Japan
EU GMP - Europe
MCC – South Africa
APIC GMP – Active Pharmaceutical Ingredient Committee (A sector group of CEFIC)
USFDA GMP – United States of America
PIC/S GMP- Germany
Schedule M – Indian
Page 8 of 48 | The Pharma Professionals Interview Guide

25. What is preventive maintenance?


It is periodic inspection and minor repairs of equipment as per schedule given in the SOP. This enables
smooth operation and long life of the equipment. It also avoids major breakdown of the equipment during
manufacturing of the product.
There are two types of maintenance.
Preventive maintenance: Schedule maintenance before any break down of machinery which prevents the
machine break down.
Breakdown maintenance: Maintenance was done after stopping machine breakdown. Weekly,
Monthly, Quarterly, Half yearly and Yearly preventive maintenance.

26. What do you mean by “Quality Assurance”?


The sum total of the organized arrangements made with the objects of ensuring that all APIs are of the
quality required for their intended use and the quality systems are maintained.

27. What are the types of different training programs?


 Induction training
 Job oriented training
 cGMP training
 On-going training

28. What is cGMP?


Current Good Manufacturing Practices. This means any procedure / system adopted by the manufacturer
which proves to be necessary and important for identity, strength and purity of a product.

29. What are the requirements for the equipment used in the manufacturing of process of API?
Material of construction used for equipment should not
 React with component
 Get corroded, cause rusting
 Impart any impurities, absorb
 Should be of appropriate design, adequate size and have smooth surface.

30. How are cGMP implemented?


Training, compliance to SOPs, control on operations, following procedures / systems, monitoring through
compliance audits.
Page 9 of 48 | The Pharma Professionals Interview Guide

31. What is solvent?


An organic or inorganic liquid used as a vehicle for the preparation of solutions or suspensions in the
manufacturing of an intermediate / API.

32. What are the classifications of residual solvents?


Residual solvents are classified into three class based on the possible risk to human health:
Class-I (Solvents to be avoided)
Class-II (Solvents to be limited)
Class-III (Solvents with low toxic potential)

33. What is the difference between Responsibility and Accountability?


Responsibility: Personnel directly associated with the implementation of the procedure
Accountability: Person directly associated with the implementation of the system under which the
procedure falls.

34. Write the names of the different countries regulatory body (Like for India, USA, UK, Australia, South
Africa, Brazil, Hungary, Germany, Philippines etc.)
India – Schedule M
United States of America – USFDA (United States Food and Drug Administration)
Australia – TGA (Therapeutic Goods Administration)
United Kingdom – MHRA (Medicines & Health care products Regulatory Agency)
South Africa – MCC (Medicine Control Council)
Brazil – ANVISA (Brazilian Health Surveillance Agency or National Sanitary Surveillance Agency)
Hungary - PIC/S (Pharmaceutical Inspection Convention or Pharmaceutical Inspection Co-operation
Scheme)
Germany – NIP (National Institute of Pharmacy)
Philippines – BFAD (Beaureu of Food and Drug)

35. What is the abbreviation of MSDS and how many contents are mentioned & what are those?
MSDS means Material Safety Data Sheet and it contains 16 contents. Those are given below:
1. Product Identification
2. Composition / Information on Ingredients
3. Hazards identification
4. First Aid measures
5. Firefighting measures
6. Accidental release measures
7. Handling & storage
Page 10 of 48 | The Pharma Professionals Interview Guide

8. Exposure controls / Personal protection


9. Physical & Chemical properties
10. Stability & Reactivity
11. Toxicological information
12. Ecological information
13. Disposal consideration
14. Transport information
15. Regulatory information
16. Other information

36. What is the static electricity?


Denoting / pertaining to electricity which is at rest. The electricity which is present on surface of a non-
conductive body, where it is trapped from escaping, is called static electricity.

37. What is the different types of Qualifications and write its flow?
Qualifications are as follows: Design Qualification, Installation Qualification, Operational Qualification,
and Performance Qualification.
URS/DS→FAT→SAT→DQ→IQ→OQ→PQ

38. What is audit/inspection and Why quality audit? Write different types of audits/inspection?
A planned and systematic examination and check of a system, procedure or operation in order to monitor
compliance with and the effectiveness of established standards and to allow for improvement and corrective
measures where required.
Quality audit because of:
 To assess the effectiveness of the quality management system
 Assessing conformance
 Investigating problems
 Continual improvement of performance
 Assessing for Registration
 Reducing cost of operation
 Legal requirement
Types:
 Study/test based inspection
 Facility based inspection
 Process based inspection
Page 11 of 48 | The Pharma Professionals Interview Guide

39. Why nitrogen gas used in the manufacturing area at room temperature and why not other gas?
Because of nitrogen is chemically less reactive and does not react with other elements at ordinary
temperature. It is due to strong bonding in its molecule.

40. What are the different types of cleanings?


There are three types of cleanings:
 Batch to Batch cleaning
 Periodically cleaning
 Product change over cleaning

41. What is blending?


Blending is defined as the process of combining materials within the same specification to produce a
homogeneous intermediate or API.

42. What is expiry date & re-test date?


Expiry date: The date place on the container / labels of an API designated the time during which the API
is expected to remain within established shelf life specifications if stored under defined conditions and
after which it should not be used.
Re-test date: The date when a material should be re-examined to ensure that it is still suitable for use. The
period of time during which the drug substance is expected to remain within its specifications and therefore,
can be used in the manufacturing of the drug product, provided that drug substance has been stored under
the defined conditions.

43. What is difference between reprocess & rework?


Reprocess: Introducing an intermediate or API, including one that does not conform to standards or
specifications, back into the process and repeating a crystallization step or other appropriate chemical or
physical manipulation steps (e.g., distillation, filtration, chromatography, and milling) that are part of the
established manufacturing process. Continuation of a process step after an in-process control test has shown
that the step is incomplete, is considered to be part of the normal process, and is not reprocessing.
Rework: Subjecting an intermediate or API that does not conform to standards or specifications to one or
more processing steps that are different from the established manufacturing process to obtain acceptable
quality intermediate or API (e.g., recrystallizing with a different solvent).

44. What is deviation & its types?


Deviation is departure from the approved destructions /established standards. There are two types of
deviation and given below:
Page 12 of 48 | The Pharma Professionals Interview Guide

Controlled / planned deviation: Any deviation from documented procedure opted deliberately for
temporary period to manage unavoidable situation or improving the performance of the operations, without
affecting the quality & yield of drug substance and safety of the operations shall be termed as controlled /
planned deviation.
Uncontrolled / unplanned deviation: Any deviation occurred in unplanned or uncontrolled manner such
as system failure or equipment breakdown or manual error shall be termed as uncontrolled / unplanned
deviation.

45. What is change control and its types?


Change control is a system that control change by
 Identifying ownership of the change
 Allowing for review and approval of the change.
 Preventing changes that could adversely affect product quality or conflict with registration or
regulatory requirement.
 Providing an assessment of change and monitors the impact of change.
 Level 1 (Minor): Are those that are unlikely to have any detectable impact on the quality attributes of
the product.
 Level 2 (Major): Are those that are likely to have a significant impact on the quality attributes of the
product.
The type of reasons for change control:
 Regulatory requirement
 GMP implementation / enhancement
 Quality improvement
 Capacity enhancement
 Introduction of new product in existing facility
 Cost reduction
 Automation
 Aging of facility
 To manage the unavoidable situation
 Market requirement

46. What is contamination and cross-contamination?


Contamination: The undesired introduction of impurities of a chemical or Microbiological nature, or of
foreign matter, in to or onto a raw material, intermediate, or API during production, sampling, packaging or
repackaging, storage or transport.
Cross-contamination: Contamination of a material or of a product with another material or product.
Page 13 of 48 | The Pharma Professionals Interview Guide

47. What is Batch number and batch?


Batch Number: A unique combination of numbers, letters, and/or symbols which identifies a batch (or lot)
and from which the production and distribution history can be determined.
Batch: A specific quantity of material produced in a process or series of processes so that it is expected to
be homogeneous within specified limits. In the case of continuous production, a batch may correspond to a
defined fraction of the production. Batch size may be defined either by a fixed quantity or the amount
produced in a fixed time interval.

48. What is quarantine?


The status of materials isolated physically or by other effective means pending a decision on their
subsequent approval or rejection.

49. What is definition of critical process parameters?


A process parameter whose variability has an impact on a critical quality attribute and therefore should be
monitored or controlled to ensure the process produces the desired quality.

50. What is mother liquor?


The residual liquid which remains after the crystallization or isolation processes. Mother liquor may contain
un-reacted materials, intermediates, levels of the API and/or impurities. It may be used for further
processing.

51. What is the difference between theoretical and expected yield?


Theoretical yield: The quantity that would be produced at any appropriate phase of production, based upon
the quantity of material to be used, in the absence of any loss or error in actual production.
Expected yield: The quantity of material or the percentage of theoretical yield anticipated at any
appropriate phase of production based on previous laboratory, pilot scale, or manufacturing data.

52. What is OOS?


Out of Specification (OOS) results are those results, generated during testing that do not comply with the
relevant specification or standards or with the defined acceptance criteria.

53. What is CAPA?


CAPA is the Corrective Action & Preventive Action.
Corrective Action: Action taken to eliminate the causes of an existing non-conformity, defect or other
undesirable situation to prevent recurrence. [Actions taken after the occurrence of a defect or problem to
stop the same from recurrence].
Page 14 of 48 | The Pharma Professionals Interview Guide

Preventive Action: Action taken to eliminate the causes of potential non-conformity, defect or other
undesirable situation to prevent occurrence. [Actions initiated before the occurrence of a defect or problem
to prevent the same occurrence].

54. What is the ICH? Write its aim/purpose and names of the different parties & different regions?
ICH means “International council for harmonization”.
Aim/Purpose: “Ensure good quality, safety and effective medicines are developed and registered in the
most effective manner, through harmonization of technical requirements”
Different Parties:
1. European commission – European Union (EMEA)
2. European Federation of Pharmaceutical Industries & Association (EFPIA)
3. Minister of health, Labor & Welfare, Japan (MHLW)
4. Japan Pharmaceutical Manufacturers Association (JPMA)
5. US Food & drugs Administration (FDA)
6. Pharmaceutical Research & Manufactures of America (PhRMA)
Different regions:
1. European Union (EMEA)
2. United States of America (USFDA)
3. Japan (MHLW)

55. What are URS, FAT, SAT, DQ, IQ, OQ, and PQ?
URS: User Requirement Specification.
FAT: Factory Acceptance Test
SAT: Factory Acceptance Test
DQ: Design Qualification
Installation Qualification (IQ): Establishing a high degree of confidence that the equipment as installed is
consistent with manufacture’s requirements and specifications.
Operating Qualification (OQ): Establishing a high degree of confidence that the equipment installed is
able to consistently operate within established limits and tolerances.
Performance Qualification (PQ): Establishing a high degree of confidence, with appropriate testing that
the equipment, under normal operating conditions, will consistently produce a quality product.

56. Difference between validation & testing?


Both are not same. Testing is defined as the identification of errors (difference between expected & actual
results) in a system. Validation is defined as documented evidence that a system performance as expected.
Page 15 of 48 | The Pharma Professionals Interview Guide

Validation includes testing but it is more – for instance, checking the documents for completeness &
correctness.

57. Why water is used extensively as a coolant in heat exchange equipments?


Because of the abundance and high heat capacity, water is used as coolant in heat exchange equipment.

58. What are the different characteristics of the fluid are to be considered while deciding its route in a heat
exchanges?
The following characteristic of the fluid are to be considered while deciding its route in a heat exchanger:
a) Viscosity b) Fouling c) Corrosiveness d) Pressure

59. When steam distillation recommended?


a) To separate appreciable quantities of higher boiling materials.
b) To separate relatively small amounts of volatile impurity from a large amount of material.
c) Where use of direct-fired heaters is detrimental to the materials.
d) Where the material is to be subjected to distillation is thermally unstable or will react with other
component associated with it at the boiling temperature.
e) Where the material cannot be distilled by in-direct heating even under low pressure because of the
high boiling temperature.

60. What is the difference between instrument & equipment?


Instrument: A device that takes a physical measurement and displays a value or has no control or analytical
functions. e.g.: Stop watch, timers & thermometer.
[A device <chemical, electrical, hydraulic, magnetic, mechanical, optical, pneumatic> used to test, observe,
measure, monitor, alter, generate, record, calibrate, manage or control physical properties, movements, or
other characteristics].
Equipment: A device or collection of components that perform a process to produce a result. [The collective
analytical measurement instruments in conjunction with firmware, assembled to perform a mechanical
process]

61. What is HVAC?


The HVAC is designed to circulate the air in the area after passing it over cooling & heating coils to maintain
the required environmental conditions & passing it through the series of filters to maintain desired
cleanliness level in the area. The air in-take and out-take of the system is designed to maintain certain degree
of pressure gradient in the area as per requirements.
Or
Page 16 of 48 | The Pharma Professionals Interview Guide

HVAC system function is to condition (heating & cooling), replace (makeup, fresh air, oxygen
replacement), and pressurize (contaminant) and clean (filter) the air in the environment to meet the required
operational conditions. To achieve this objective, electrical, mechanical & electronic components are
arranged in several configurations such that they produce the expected results.

62. What is the meaning of Q, S, E, M in the ICH?


“Q” stands for Quality;
“S” stands for Safety,
“E” stands for Efficacy and
“M” stands for Multi-disciplinary

63. How many guidelines are present in Q & what are those, describe in detail?
In Quality (Q), total 12 guidelines are present. Those are as follows:
1. Q1 - Stability
2. Q2 - Analytical Method validation
3. Q3 - Impurities
4. Q4 - Pharmacopoeia
5. Q5 - Biotechnological quality
6. Q6 - Specification
7. Q7 - Good Manufacturing Practice (GMP)
8. Q8 - Pharmaceutical Development
9. Q9 - Quality Risk Management
10. Q10 - Pharmaceutical Quality System
11. Q11 - Development and manufacture of Drug Substances
12. Q12 - Life cycle management

64. How many types of raw material and packing material?


Raw materials are classified into two types. Those are as follows:
1. Key raw material
2. Other raw material
Packing materials are classified into two types. Those are as follows:
1. Primary Packing material
2. Secondary Packing material
Page 17 of 48 | The Pharma Professionals Interview Guide

65. Define the Key raw material/ starting material & primary packing material?
Key raw material/starting material: Starting material shall be defined as that which is
 Incorporated as a significant structural fragment of the API / Drug Intermediate and
 Having significant effect on the Quality and Yield of the product.
 Starting material shall be identified in TDP.
Primary Packing material: Packing material, which come in direct contact with the API/Intermediate are
considered as Primary packing material.

66. What is cleaning validation?


 Cleaning validation is documented evidence that an approved cleaning procedure will provide
equipment which is suitable for processing of pharmaceutical products or APIs.
 Cleaning validation is the confirmation of reliable cleaning products so that the analytical monitoring
may be omitted or reduced to a minimum in the routine phase.
 It describes the validation of cleaning procedures for the removal of contaminants associated with the
previous products, residues of cleaning agents as well as the control of potential microbial contaminants.

67. What are the sampling techniques used in the cleaning validation?
Swab sampling: Areas which are reasonably accessible & hardest to clean can be evaluated, leading to
level of contamination or residue per gives surface area.
Rinse sampling: Large areas or parts of equipments which could not be swabbed should be rinse sampled
or directly extracted by solvent. Tubes, nozzles, pipes or containers with surface those are not reasonably
accessible for direct surface sampling have to be rinsed with solvent. In addition, inaccessible areas of
equipment that cannot be routinely disassembled can be evaluated.

68. What parameters considered during performance qualification of HVAC?


The following parameters are to be considered during the performance qualification of HVAC:
Calibration test certificates of instruments
Training records of validation team
Pressure drop across the HEPA & fine filters
Air velocity measurement & calculation of Air changes
Integrity test of HEPA filter
Differential pressure test
Temperature & Relative Humidity test
Air flow direction test
Cleanliness class verification (Non-viable particle count)
Sound level test
Page 18 of 48 | The Pharma Professionals Interview Guide

Light level test


Air borne viable particle monitoring
Recovery Study

69. What are the contents in the BPCR?


BPCR contains the following contents, but not limited:
Product Name
Stage
BPCR Document Number
MPCR Reference Number
Batch Number
Date of Manufacturing
Date of Expiry/Re-test
Batch release details
List of equipments used
List of raw materials & Quantity with UOM
General instructions, Control & Safety instructions
Detailed step wise written manufacturing procedures
Actual results record for critical process parameters
Identity of In-process & Laboratory test results
Signatures of person performing details along with supervising details
Description of Packaging details
Yield calculation
Representative of labels for intermediates / raw materials
Deviation details
Batch starting & completion date

70. What is OOT and define?


“OOT” stands for Out Of Trend. It means any test results obtained for a particular batch that is markedly
different the results of the batches in a series obtained using a same validated method.

71. How will you prevent cross-contamination between two different products manufactured in the one
production block?
By maintaining the proper pressure differential between the rooms with two Air handling units (if re-
circulation) / one Air handling unit (if 100% fresh air)
Page 19 of 48 | The Pharma Professionals Interview Guide

72. What is limit of Temperature and relative humidity in the pharma area?
Temperature: 25±2˚C & Relative Humidity: 50±5%

73. What is the difference between dedicated and non-dedicated equipments?


Dedicated equipment: It is used solely for the production of a single product or product line. Concerns
over cross-contamination with other products are markedly reduced. Dedicated equipments must be clearly
identified with the restrictions of use in order to prevent potential errors during cleaning and preparation.
Non-dedicated equipment: Where the same piece of equipment is utilized for a range of products
formulations. The prevention of cross-contamination between products becomes the main objective in the
cleaning validation effort. Clearly, cleaning non-dedicated equipments represents a more significant
obstacle to overcome.

74. Which instrument is used for the measuring of RPM?


Taco meter is used for the measurement of RPM.

75. Why three batches consider for the validation?


Because of First one is for information, Second one is for confirmation and Third one is for evidence.

76. If one batch is failed during the validation, then what will you do for completion of validation?
 When a quality parameter fails with respect to the specification, a deviation report shall be raised
and the investigation shall be conducted immediately for the identification of failure.
 If the reason for failure is identified, one more consecutive batch shall be considered for the
validation run by taking preventive actions to avoid those failures (If necessary revise the MPCR
and BPCR).
 If the reason is unidentified, another three consecutive batches shall be taken for validation

77. Write the different storage conditions as per any guidelines (specify the name of guideline)?
The different storage conditions are given below as per USP:
Freezer : -25°C to -10°C
Cold : Any temperature not exceeding 8°C
Refrigerator : Between 2°C and 8°C
Cool : 8°C to 15°C
Room temp. : The temperature at prevailing working area.
CRT : 20°C to 25°C
Warm : 30°C to 40°C
Excessive heat : Above 40°C
Page 20 of 48 | The Pharma Professionals Interview Guide

78. Write the different types of fires,which are generally used in the pharmaceutical industry?
A. Chemical fire
B. Electrical fire
C. Metal fire
D. General fire
E. Kitchen fire

79. What is ISO 9001, ISO 14001, ISO 18001, and ISO 22001?
ISO 9001 : Quality Standard Management
ISO 14001 : Environmental Standard Management
ISO 18001 : Safety & Health Standard Management
ISO 22001 : Hazop Standard Management

80. What is HACCP?


HACCP : Hazard Analysis Critical Control Point

81. What is OHSAS?


OHSAS : Occupational Health & Safety Assessment Series

82. Why one liter of water is equivalent to one kilogram of water at room temperature?
Because of at normal room temperature is between 25°C and 35°C at plant operating condition and the
variation in weight Vs. Liter of water is negligible compared to volume.

83. What is room temperature?


The temperature at prevailing working area.
84. What is calibration?
The demonstration that a particular instrument or device produces results within specified limits by
comparison with results produced by a reference or traceable standard over an appropriate range of
measurements

85. What is the maximum time allowed after cleaning with water as last rinse?
Equipment should not be left with water it after cleaning. The last step of the cleaning procedures involve
drying with solvent or flushing with nitrogen, thus ensuring that there is no opportunity for microbial
growth.

86. What is the efficiency of the High Efficiency Particulate Air (HEPA) filter?
This type of air filter can remove at least 99.97% particles in air up to 0.3μm in diameter.
Page 21 of 48 | The Pharma Professionals Interview Guide

87. What is the micron size of HEPA filter?


The micron size of HEPA filter is 0.3μm

88. If two different products are manufacturing in two modules of one production block, then will you accept
the common air handling unit for both pharma area? Write “Yes” or “No” with reason?
No, because of cross-contamination (if re-circulation of return air)
Yes, if 100% of fresh air is circulated through the respective area.

89. Why blending validation is required? What quality parameters of product are considered for validation
and what parameters of equipment are to be considered during validation?
Because of to provide sufficient documented evidence to assure that the blending operation of product is
capable of repeatedly and reliably producing a homogeneous material to meet established specifications
when operated under defined standard conditions.
The following Quality parameters are to be considered, but not limited:
 Loss on Drying / Water content
 Bulk density / tapped density
 Residual solvent
 Particle size
The following parameters are to be considered for the equipment during validation, but not limited:
 Blender capacity
 RPM of the blender
 Occupancy of the blender
 Number of individual batches to be taken for each blend
 Mixing time
90. What is the formula for calculation of “Air changes per hour” during HVAC validation?
Total CFM of the blower/Filter x 60
Air changes per hour= ----------------------------------------------------
Total room volume

91. During the performance qualification in the vacuum tray dryer,how many temperature probs used?
Total 16 to 24 temperature probes are to be kept during the performance qualification of the vacuum tray
dryer (or number of probes specified in the protocol)

92. What is the formula for the calculation of “MACO” while cleaning between one API to another API?
Minimum therapeutic dosage of previous product X Minimum batch size of next product
MACO = ---------------------------------------------------------------------------------------------------------
Safety factor X Maximum therapeutic dosage of the next product
Page 22 of 48 | The Pharma Professionals Interview Guide

93. What is the limit for “Individual unknown Impurity” in API as per ICH Q2A?
The limit of the “Any individual unknown Impurity” is not more than 0.1%

94. What are the class-I solvents as per ICH Q3C?


Benzene - 2 ppm Carbon tetrachloride - 4 ppm
1,2-Dichloroethane - 5 ppm 1,1-Dichloroethene - 8 ppm
1,1,1-Trichloroethane - 1500 ppm

95. What is the abbreviation of CAS Number?


CAS Number: Chemical Abstract Service Number

96. What is the specific gravity of Methylene chloride?


Specific gravity of Methylene chloride is 1.308 g/ml
97. If equipment is cleaned with water, then finally it should be rinse with suitable solvent as per guidelines,
why?
Because of the last step of the cleaning procedures involve drying with solvent or flushing with nitrogen,
thus ensuring that there is no opportunity for microbial growth.

98. What is mean by “4M”?


“4M” means Man, Machine, Method and Material

99. If supposed your pharma area is class 100000, then what is the maximum light and sound level as per
guidelines?
The light & sound level limits are given below for class 100,000 / ISO 8:
Light Level : Not less than 300 Lux
Sound Level: Not more than 80 decibels

100. Write the classification of contaminants in clean rooms?


Substance:
Physical : Dust, Dirt, Grit, Fiber, Lint & Fly ash
Chemical : Organic compound, Inorganic salts, vapor, mist, fume & smoke
Biologic : Bacteria, Fungus, Spore, Pollen, Virus, Human skin & cells

Energy:
Thermal, Light, Electromagnetic (EMI), Electrostatic (ESD), Radiation & Electrical
Page 23 of 48 | The Pharma Professionals Interview Guide

101. What is mean by “Clean-in-Place” and “Clean-out-Place”?


Clean-in-Place: The cleaning of large pieces of equipment may be performed in the equipments permanent
location. Generally, in a configuration very similar to that in which it is utilized for production. This
procedure widely known as Clean-in-Place (CIP)
Clean-out-Place: The smaller items are frequently transported to a designated cleaning or washing area
where the cleaning procedures is performed. This practice is known as clean-out -place (COP)

102. What is the name of the instrument, which is used for measuring of vacuum (in Tars) during high
vacuum distillation?
Macleod gauge

103. Is cGMP requirement only for personnel in the manufacturing?


No, this requirement is for each and every employee of the organization who must know the relevant cGMP
requirements in his/her area.

104. Why cGMP should be followed?


This is a regulation that each one of us is trained in cGMP and practices cGMP
- It minimizes the possibilities of any errors caused by subjectivity.
- It makes you do your job right the first time and every time.

105. For which areas do we have SOPs?


We have SOPs for the following areas:
Quality Assurance
Quality Control
Production
Personnel
Warehouse
Safety & Environment
Engineering
Facility Management
Information technology

106. Why do we conduct trainings?


It brings awareness and helps us in becoming competent.
Page 24 of 48 | The Pharma Professionals Interview Guide

107. What is personal hygiene?


Each personal should:
Wear clean uniform
Take bath daily
Report illness or injury
Be medically fit
Develop good hygiene habits

108. What are cGMP requirements for building and facilities?


Following are the cGMP requirements:
Suitable size, construction and location
Facilitate cleaning, maintenance and proper operation
Adequate space
Defined areas of adequate size
Water supply: continuous and of good quality
Power supply: continuous
Adequate lighting, ventilations, air filtration, plumbing sewage, toilet facilities

109. What is mean by designated area?


By designated area we mean: Specific area for a specific operation:
E.g. packing operation shall be carried out only in packing room and not elsewhere.

110. How do we know that the gauges are ok?


Gauges are periodically calibrated and they bear the calibration status tag.

111. What is in-process control?


Monitoring the manufacturing process at different stages is called in-process control. In-process control of
the process provides an acceptable and achievable level of built in quality assurance for the product. This is
possible through appropriate GMP during all manufacturing steps.
Or
Checks performed during production in order to monitor and, if necessary to adjust the process and / or to
ensure that the intermediate or API conforms to its specifications.

112. What is critical process parameter?


A process parameter whose variability has an impact on a critical quality attribute and therefore should be
monitored or controlled to ensure the process produces the desired quality.
Page 25 of 48 | The Pharma Professionals Interview Guide

Or
A process condition or material or a test when it is essential to maintain a predetermined rage in order to
reproducibly meet the specification is called critical parameter. Critical parameters have direct impact on
the quality of a product.

113. What precautions are to be observed while working in the powder processing room?
Following precautions should be observed while working in the powder processing rooms:
Absolute discipline w.r.t complete uniform
Bunny suit, clean shoe covers, hand loves, snoot mask etc. and SOPs compliance
Positive pressure
House keeping
Avoid foreign objects (pens, pencils, tools etc.)
Identification / status card on materials
Stage slips on equipments
Temperature (less than 25°C)
Avoid extraneous contamination from dust, insects, micro-organism, foreign particles etc.
Check the condition of sieves used in multi mill and sifter
Cleaning and calibration of weighing balances
Usage of fresh, clean drums and poly bags for final packing.

114. What precautions do we take during storage of API?


All APIs are stored under controlled conditions of temperature and humidity in their designated area.
 Records of temperature and humidity are maintained on daily basis.
 Housekeeping is done on daily basis and records are kept for the same.
 Insects, pests and rodent control procedures are follows.

115. What is mean by the word “Quality”?


Quality is basically customer’s satisfaction through sensitivity.
Or
A measure of a product’s or service’s ability to satisfy the customer’s stated or implied needs.

116. Inspection can be of three types, what are those? Inspections are three types:
Study /test based inspection
Facility based inspection
Process based inspection
Page 26 of 48 | The Pharma Professionals Interview Guide

117. Define stability study and its necessity?


Stability study is defined as “stability testing is to provide evidence how quality varies with time under
influence as: temperature, humidity & light”
Establish re-test period for drug substance
Establish shelf life for drug product
Recommended storage conditions

118. What are the different types of stability study conditions as per ICH guidelines?
General storage conditions:
Name Temperature (°C) Relative humidity (%)
Long term 25±2 60±5
Intermediate 30±2 65±5
Accelerate 40±2 75±5
Storage in a Refrigerators:
Long term 5±3 NA
Accelerate 25±2 60±5
Storage in a Freezer:
Long term -20±5 NA

119. What do you mean by “Reference standard” and “Working standard”?


Reference Standard: A substance that has been shown by an extensive set of analytical tests to be authentic
material that should be of high purity. This standard may be obtained from an officially recognized source
or may be prepared by independent synthesis or by further purification of existing production material.
Working Standard: A substance of established quality and purity, as shown by comparison to a primary
reference standard, used as a reference standard for routine laboratory analysis

120. What is abbreviation of CTD?


“CTD” means Common Technical Document. This is addressed in the ICH guidelines in the section of
“M” and in the part of “M4”

121. What do you mean by market complaint?


Any communication, written or verbal, received regarding the quality, packing directly from any traders or
product manufacturer and marketing staff or any other such complaints shall be considered as a Market
Complaint.
Page 27 of 48 | The Pharma Professionals Interview Guide

122. What is maximum time period for the sending of the final response to concerned customer regarding the
market complaint?
Within 30 days or as specified in the Market compliant SOP

123. Describe the categories of the market complaints?


Market complaints are categorized into three types and are as follows:
Critical: Complaints related to suspected contamination, adulteration and mislabeling.
Major: Complaints related to the product not meeting its pre-determined critical specifications and damage
to primary packaging.
Minor: Complaints related to the product not meeting non-critical quality attributes, or damage to secondary
packaging or shortages etc.

124. What are the types of non-compliances in the internal audit?


Non-compliances shall be categorized as follows:
Critical: Those findings that warrant stoppage of any further operations in the facility until the corrective
actions have been completed.
Major: Those findings that require immediate corrective action plan and compliance although operations
can be continued.
Minor: Those findings that require corrective action plan as agreed between the Auditee department Head
and Quality Assurance.

125. How many phases are divided the performance qualification of purified water system and write the
duration of each phase?
Performance qualification of purified water system is divided into the three phases and described below:
Phase-I:
Develop & finalize operating, preventive maintenance, sanitization procedures.
Demonstrate production & delivery of water of required quality.
To finalize SOP on sanitization, Alert & Action limits.
Phase – I shall be conducted for 30 days.
Phase-II:
Demonstrate consistent operation within established ranges.
Demonstrate consistent production & delivery of water of required quality.
Phase – II shall be conducted for 30 days.
Phase-III:
Demonstrate extended performance.
Ensure that potential seasonal variations are evaluated & treated.
Phase-III shall be conducted for 10 - 12 months
Page 28 of 48 | The Pharma Professionals Interview Guide

126. What is the abbreviation of “TDP” and its contents?


“TDP” means Technical Data Package and shall contain the following contents, but not limited:
Brief manufacturing process
Solvents used in the manufacture
Impurity profile
Working standard profile (If any)
Characterization data (if any)
Specifications and test procedures of the supplier
TSE / BSE free Certificate
Stability studies/ Hold time data
Storage conditions
Packing details
MSDS
Certificate Of Analysis (COA)
DMF Number (if any)

127. What are the QA activities during the vendor qualification for Key starting raw material, give flow chart?
Page 29 of 48 | The Pharma Professionals Interview Guide

128. What are the QA activities during the vendor qualification for Primary packing material, give flow chart?

129. What do you mean by “worst case”?


A condition or set of conditions encompassing upper and lower processing limit and circumstances, within
standard operating procedures, which poses the greatest chance of product or process failure when compared
to ideal conditions. Such conditions do not necessarily induce product or process failure.

130. What do you mean by “performance qualification”?


The performance qualification documents describes the procedures for demonstrating that a system / piece
of equipment can consistently perform & meet required specifications under routine operation and where
appropriate, under worst case situations.

131. Describe about swab and rinse sampling?


Swab: Areas which are reasonably accessible & hardest to clean can be evaluated, leading to level of
contamination or residue per given surface area.
 Take the clean swab having surface area of 10mmX10mm
 Put the swab in the test tube containing 10 ml suitable solvent and squeeze the swab along the sides
of the test tube to remove the excess of water from it.
 Identify the locations for swab sampling
 Take out the wet swab from the test tube without touching the tip of swab.
Page 30 of 48 | The Pharma Professionals Interview Guide

 Place the one side of swab over the identified location and apply it on the 10 X 10 sq. cm area first
in vertical fashion without changing face of the swab
 Turn the swab to other side and apply it on the area in horizontal fashion covering all the areas
 Place the swab stick in to the test tube having 10 ml suitable solvent without touching the tip.
 Lave the test tube with the location

Rinse: Large area or parts of equipments which could not be swabbed should be rinse sampled or directly
extracted by solvent. The areas which are not reasonably accessible for direct surface sampling have to be
rinsed with suitable solvent.
 Use specified volume of suitable solvent for rinsing
 Rinse the identified locations using the following procedure
 Take specified quantity of suitable solvent in a graduated bucket
 Use a clean mug to splash the solvent in the reactor
 Close the bottom valve of the reactor
 Take solvent in the mug splash at all side of the reactor
 Attention to be applied particularly on the blind sides in the inside top of the reactor
 Splash the solvent at the agitator shaft and blades
 Open the bottom valve and collect the washed solvent in a clean bucket. Collect about 100 ml
(specified quantity in the protocol) in a sample bottle from the bucket. Close the lid and label it
properly.
 When more than one equipment is involved (equipment chain) for rinsing, suitable quantity of
solvent shall be used and the rinse volume shall be measured.

132. What is the difference between specification and Limit?


Specification: A document giving a description of a starting material, packaging material, intermediate,
bulk or finished product in terms of its chemical, physical & possibly biological characteristics. A
specification normally includes description clauses & numerical clauses, the latter stating standards &
permitted tolerances.
Or
It is the type of standard which is often referenced by a contract or procurement document. It provides the
necessary details about the specific requirements.
Or
Lists of detailed requirements with which the products/ materials used or obtained during manufacture have
to conform. They serve as a basis for quality evaluation.
Limit: The point, edge or line beyond which something cannot or may not be proceed. The boundary
surrounding a specific area, bounds.
Page 31 of 48 | The Pharma Professionals Interview Guide

133. What are the possible causes for “Out of Specification”?


The following are the possible causes for out of specification:
Test analysis error in QC Lab.
Lab equipment malfunctioning or off-calibrated
Production equipment malfunctioning or off-calibrated
Operator/human errors

134. What is the clean room specifications for different classes (for >= 0.5 μm and >=5.0 μm particles) as
per EU GMP/US 209E/ISO 14644-1/ Schedule M/ WHO GMP?
Page 32 of 48 | The Pharma Professionals Interview Guide

135. What is the definition of document control?


Document control ensures that documents are reviewed for adequacy, approved for release by authorized
personnel and distributed to and used at the location where the prescribed activity is performed.

136. What is the difference between controlled copy and un-controlled copy?
Controlled copy: A controlled copy is a formal copy of the latest, correct issue of a document; an identified
issue of a document to an individual or location of record. The controlled copy is officially tracked, updated
& destroyed to assure that it is current.
Uncontrolled copy: An informal copy of a document for which no attempt is made to update if after
distribution; the document is marked “uncontrolled” and the user determines if the document is active prior
to use.

137. What do you mean by re-validation?


A repeat of the process validation to provide an assurance that changes in the process/equipments
introduced in accordance with change control procedures do not adversely affect process characteristics &
product quality.

138. What are the system suitability parameters in the method validation?
Tailing factor, Theoretical plates, Relative Standard deviation (RSD), Resolution, Retention time (RT),
Relative retention time (RRT), Capacity factor.

139. What is commissioning?


An engineering term that covers all aspects of bringing a system /sub-system to a position where it is
regarded as being ready for use in pharmaceutical manufacture. Commissioning involves all the basis
requirements of Installation qualification (IQ) & Operational Qualification (OQ).

140. When to qualify & validate?


Any aspect of, including significant change to the premises, the facilities, the equipment or the process,
which may affect the quality of the product, directly or indirectly, should be qualified and validated.
Page 33 of 48 | The Pharma Professionals Interview Guide

141. What are the advantages of Swab sampling?


 Dissolves & physically removes sample
 Adaptable to a wide variety of surfaces
 Economical & widely available
 May allow sampling of a defined area
 Applicable to active, microbial & cleaning agent residues.

142. What are the advantages of Rinse sampling?


 Adaptable to on lime monitoring
 Easy to sample
 Non-intrusive
 Less technique dependent that swab
 Applicable for active, cleaning agents & excipients allow sampling of a large surfaces
 Allows sampling of unique (e.g. porous) surface.

143. What are the different climate zones in the world?


World is divided into the Five climate zones and are given below:
Zone Name Conditions
I Temperate 21° C / 45% RH
II Subtropical & Mediterranean 25° C / 60% RH
III Hot & Dry 30° C / 35% RH
IVA Hot & Humid 30° C / 65% RH
VB Hot & Very Humid 30° C / 75% RH
144. What is a DMF?
A DMF is a package of proprietary information filed voluntarily by a company with the FDA. If it held by
them in confidential closed files until such time as an FDA reviewer requests a review of the DMF.
145. What are the types of DMF?
There are four types of DMF. They are referred to by their numbers in Roman numerals:
Type-II: DMF is for companies who supply drug substances, drug products, intermediates & material used
in their manufacture.
Type-III: DMF is for companies who supply packaging (container closure system) for human drugs &
biologics.
Type-IV: DMF is for companies who supply excipients
Type-V: DMF is for companies who supply clinical services, sterile manufacturing etc.
Type-I: Is an obsolete number once used for a category that no longer exists because it was found to easily
fit into and overlap with the other four categories.
Page 34 of 48 | The Pharma Professionals Interview Guide

146. What are the possible reasons for the Non-conformities?


The following are the possible reasons, but not limited:
 Management attitude
 Ineffective documentation
 Lack of trained personnel
 Lack of co-ordination / co-operation within or among departments.
147. What do you mean by Critical Quality Attributes?
A critical quality attributes is a physical, chemical, biological or microbiological property or characteristic
that should be within an appropriate limit, range, or distribution to ensure the desired product quality.

148. What are the test parameters in the nitrogen gas validation?
Test parameters during validation and its frequency are given below:
a) Test for oil mists - Every 6 months once
b) Test for moisture content - Every 6 months once
c) Particulate count (Non-viable) - Every 6 months once
d) Sterility test (Aseptic area locations) - Every 6 months once
e) Bio burden test (Controlled area locations) - Every 6 months once
* Perform the nitrogen gas sampling & testing for three consecutive days.
f) Purity of nitrogen gas (Based on manufacturer COA)
149. What do you mean by Non-conformity?
Non-conformity is non-fulfillment of a specified or implied requirement of the quality management system
or of a quality work product.
150. Describe the method of testing for checking of MOC of SS material (Molybdenum test)?
Procedure:
 Put one drop of electrolyte solution of molybdenum test kit on clean metal surface, which is to be
tested.
 Switch on the detector and touch the metal tip of the detector on metal surface & carbon point in
electrolyte solution.
 Do not pass the current for more than 3 to 4 seconds
 If the red color appears and is stable for more than 2 seconds then it can be concluded that MOC of
the part being tested is SS-316.
 If the solution remains colorless or green color appears then it can be concluded that MOC of the part
being tested is SS-304.
 If the black color appears & is stable for more than 2 seconds then it can be concluded that MOC of
the part being tested is SS-302.
Page 35 of 48 | The Pharma Professionals Interview Guide

151. What do you mean by production?


All operations involved in the preparation of an API from receipt of material through processing and
packaging of an API.

152. Define Bio burden?


The level & type (i.e. objectionable or not) of microorganisms that can be present in raw materials, API
starting materials, intermediates or APIs. Bio burden should not be considered contamination unless the
levels have been exceeded or defined objectionable organisms have been detected.

153. What is the necessity of analytical method validation?


The principle purpose of analytical validation is to ensure that a selected analytical procedure will give
reproducible and reliable results that are adequate for the intended purpose. It is thus necessary to define
properly both the conditions in which the procedure is to be used & the purpose for which it is intended.

154. What are the different types of safety factors used in the pharmaceutical industries?
1/10 to 1/100th of normal daily dose = Topical products
1/100 to 1/1000th of normal daily dose = Oral products
1/1000 to 1/10000th of normal daily dose = Inject able & Ophthalmic products
1/10000 to 1/100000th of normal daily dose = Research, investigational products.

155. What do you mean by reconciliation?


A comparison, making due allowance for normal variation, between the amount of product or material
theoretically & actually produced/used.

156. What are the contents of Annual product quality review (APQR)?
1. Introduction
2. Number of Intermediates and APIs batches produced
3. Review of output for all Isolated Intermediates and Finished Products
4. Review of Critical Quality attributes of In-process, Isolated Intermediates and Finished Products
5. Summary of changes made during the year with respect to equipment, Process, Specifications, and
Methods, Raw materials and others.
6. List of Deviations and a brief description of deviations and action taken.
7. List of customer complaints; Return goods and Recalled goods along with description and actions taken.
8. Number of Reprocessed and Reworks batches in all stages during the year.
9. Review of Key starting materials and Primary packing materials and Rejections.
10. Review of Bio burden on product (for minimum of 3 batches)
Page 36 of 48 | The Pharma Professionals Interview Guide

11. Review on Stability studies and Summary


12. List of Out of specifications for finished products
13. Review on Retained samples quality (Finished product)
14. Review on Validation packages (Process, Equipment, and Procedure)
15. Status of Drug Master File (if any), Drug Master File new updates
16. Details of special training provided to employees in case of Deviations or Complaints received regarding
a particular product
17. Summary Report
157. Which solvents are categorized in the organic volatile impurities (OVI)?
Methylene chloride - 600 ppm
Chloroform - 60 ppm
1,1,2-Tri chloro ethylene - 80 ppm
1,4-Dioxane - 380 ppm

158. What do you mean by customer satisfaction?


Customer’s perception of the degree to which the customer’s requirements have been fulfilled Any
customer wants three things:
 Good product
 Timely feedback
 Timely supply

159. What is the QMS?


It is the quality management system to direct and control an organization with regard to quality.

160. What do you mean by pre-determined acceptance criteria?


The criteria assigned, before undertaking testing to allow evaluation of test results to demonstrate
compliance with a test phase of delivery requirement.

161. What is Master validation Plan (VMP)?


A document providing information on the company’s validation work program. It should define details of
and timescales for the validation work to be performed. Responsibilities relating to the plan should be
stated.

162. What do you mean by product recall?


Products recall means removal or withdraw of marketed material due to violation in laws & regulations as
per regulatory authorities or not conforming to the customers’ specifications.
Page 37 of 48 | The Pharma Professionals Interview Guide

163. What do you mean by residual solvent?


These are the traces of the solvents left during the manufacturing of drug substances or drug products.
Residual solvents are not completely removed by practical manufacturing techniques.

164. How can we avoid contaminations in warehouse?


Contamination can be avoided by:
 Proper segregation / identification of different RMs
 Following good housekeeping procedures
 Having dedicated sampling tools for each RM
 Segregated rejected materials
 Segregated storage of penicillin RMs
 Separate sampling booth/enclosure for RMs

165. What is retention sample & why retention sample is preserved?


A part of the sample which is representative of the released batch of a finished product preserved beyond
its shelf life.
It is preserved for future reference / reanalysis in cases of market complaints or development work or any
other clarification about the released batch.

166. What will happen if cGMP are not followed?


Non-compliance to cGMP may lead to:
• Poor quality of product / services
• Batch failure
• Market complaints and product recalls
• Company’s reputation affected
• Business will be affected
• Regulatory action
• Injuries or accidents
• Equipment failures
167. What are the safety systems in the plant?
Some of the safety systems used in the plant are:
 Eye washer, safety showers
 Fire extinguishers
 Fire hydrants
 Face shields
 Goggles
 Helmets
Page 38 of 48 | The Pharma Professionals Interview Guide

 Nose masks
 Safety shoes
 Safety belts
 Hand gloves
 Training on safety rules and use of safety equipment.

168. Would you like to recommend any precautions while operating the equipment?
Following precautions are recommended:
 Make sure that each equipment is numbered and its log is maintained.
 Check whether the equipment is cleaned as per SOP
 Always follow product changeover procedure during product changeover
 Take care of safety rules
 Monitor operating conditions
169. What are the contents of ICH Q7A GMP guidelines?
I. INTRODUCTION
A. Objective
B. Regulatory Applicability
C. Scope
II. QUALITY MANAGEMENT
A. Principles
B. Responsibilities of the Quality Unit(s)
C. Responsibility for Production Activities
D. Internal Audits (Self Inspection)
E. Product Quality Review
III. PERSONNEL
A. Personnel Qualifications
B. Personnel Hygiene
C. Consultants
IV. BUILDINGS AND FACILITIES
A. Design and Construction
B. Utilities
C. Water
D. Containment
E. Lighting
F. Sewage and Refuse
G. Sanitation and Maintenance
Page 39 of 48 | The Pharma Professionals Interview Guide

V. PROCESS EQUIPMENT
A. Design and Construction
B. Equipment Maintenance and Cleaning
C. Calibration
D. Computerized Systems
VI. DOCUMENTATION AND RECORDS
A. Documentation System and Specifications
B. Equipment Cleaning and Use Record
C. Records of Raw Materials, Intermediates, API Labeling and Packaging Materials
D. Master Production Instructions (Master Production and Control Records)
E. Batch Production Records (Batch Production and Control Records)
F. Laboratory Control Records
G. Batch Production Record Review
VII. MATERIALS MANAGEMENT
A. General Controls
B. Receipt and Quarantine
C. Sampling and Testing of Incoming Production Materials
D. Storage
E. Re-evaluation
VIII. PRODUCTION AND IN-PROCESS CONTROLS
A. Production Operations
B. Time Limits
C. In-process Sampling and Controls
D. Blending Batches of Intermediates or APIs
E. Contamination Control
IX. PACKAGING AND IDENTIFICATION LABELING OF APIs AND INTERMEDIATES
A. General
B. Packaging Materials
C. Label Issuance and Control
D. Packaging and Labeling Operations
X. STORAGE AND DISTRIBUTION
A. Warehousing Procedures
B. Distribution Procedures
XI. LABORATORY CONTROLS
A. General Controls
B. Testing of Intermediates and APIs
Page 40 of 48 | The Pharma Professionals Interview Guide

C. Validation of Analytical Procedures


D. Certificates of Analysis
E. Stability Monitoring of APIs
F. Expiry and Retest Dating
G. Reserve/Retention Samples
XII. VALIDATION
A. Validation Policy
B. Validation Documentation
C. Qualification
D. Approaches to Process Validation
E. Process Validation Program
F. Periodic Review of Validated Systems
G. Cleaning Validation
H. Validation of Analytical Methods
XIII. CHANGE CONTROL
XIV. REJECTION AND RE-USE OF MATERIALS
A. Rejection
B. Reprocessing
C. Reworking
D. Recovery of Materials and Solvents
E. Returns
XV. COMPLAINTS AND RECALLS
XVI. CONTRACT MANUFACTURERS (INCLUDING LABORATORIES)
XVII. AGENTS, BROKERS, TRADERS, DISTRIBUTORS, REPACKERS, AND RELABELLERS
A. Applicability
B. Traceability of Distributed APIs and Intermediates
C. Quality Management
D. Repackaging, Re-labeling, and Holding of APIs and Intermediates
E. Stability
F. Transfer of Information
G. Handling of Complaints and Recalls
H. Handling of Returns

XVIII. SPECIFIC GUIDANCE FOR APIs MANUFACTURED BY CELL CULTURE/


FERMENTATION
A. General
Page 41 of 48 | The Pharma Professionals Interview Guide

B. Cell Bank Maintenance and Record Keeping


C. Cell Culture/Fermentation
D. Harvesting, Isolation and Purification
E. Viral Removal/Inactivation steps
XIX. APIs FOR USE IN CLINICAL TRIALS
A. General
B. Quality
C. Equipment and Facilities
D. Control of Raw Materials
E. Production
F. Validation
G. Changes
H. Laboratory Control
I. Documentation
XX. GLOSSARY

170. What are the contents of the Drug Master File as per CTD Format?
Module-I:
1.1 Comprehensive Table of Contents
1.2 Application Form
1.3 Summary of Product Characteristics, Labeling and Package Leaflet
1.3.1 - Summary of Product Characteristics
1.3.2 - Labeling
1.3.3 - Package Leaflet
1.3.4 – Mock-ups and specimens
1.3.5 – SPCs already approved in the Member States
1.4 Information about the Experts
1.5 Specific requirements for different types of applications
1.5.1 Information for bibliographical applications under Art.4.8 (a) (ii) of Dir 65/65
1.5.2 Information for abridged applications under Art.4.8 (a) (iii) of Dir 65/65, 1st and 2nd
paragraph
Annexure: Environmental Risk Assessment
Module-2 (QOS):
2.1 CTD Table of Contents (Module 2 – 5)
2.2 CTD Introduction
2.3 Quality Overall Summary
Page 42 of 48 | The Pharma Professionals Interview Guide

2.4 Non-clinical Overview


2.5 Clinical Overview
2.6 Non-clinical Written and Tabulated Summary
 Pharmacology
 Pharmacokinetics
 Toxicology
2.7 Clinical Summary
 Bio pharmaceutics and Associated Analytical Methods
 Clinical Pharmacology Studies
 Clinical Efficacy
 Clinical Safety
 Synopses of Individual Studies
Note: The contents of Quality Overall Summary are described below:
Quality Overall Summary
2.3. S Drug Substance
2.3. S.1 General Information
2.3. S.2 Manufacture
2.3. S.3 Characterization
2.3. S.4 Control of Drug substance
2.3. S.5 Reference standards or materials
2.3. S.6 Container closure system
2.3. S.7 Stability
2.3. R Regional Information
Module-3 (Quality):
3.2. S Drug Substance
3.2 S.1 General Information
3.2.S.1.1 Nomenclature
3.2.S.1.2 Structure
3.2.S.1.3 General Properties
3.2. S.2 Manufacture
3.2.S.2.1 Manufacturers
3.2.S.2.2 Description of Manufacturing Process and Process Controls
3.2.S.2.3 Control of Materials
3.2.S.2.4 Controls of Critical Steps and Intermediates
3.2.S.2.5 Process Validation and/or Evaluation
Page 43 of 48 | The Pharma Professionals Interview Guide

3.2.S.2.6 Manufacturing Process Development


3.2. S.3 Characterization
3.2.S.3.1 Elucidation of Structure and other Characteristics
3.2.S.3.2 Impurities
3.2. S.4 Control of Drug substance
3.2.S.4.1 Specification
3.2.S.4.2 Analytical Procedures
3.2.S.4.3 Validation of Analytical Procedures
3.2.S.4.4 Batch Analyses
3.2.S.4.5 Justification of Specification
3.2. S.5 Reference standards or materials
3.2. S.6 Container Closure system
3.2. S.7 Stability
3.2.S.7.1 Stability Summary and Conclusions
3.2.S.7.2 Post approval Stability Protocol and Stability Commitment
3.2.S.7.3 Stability Data

171. Write the different parts of 21 CFR and details of different subparts of 21 CFR 211?
21 CFR Part 11 : Electronic records, Electronic signatures, Electronic copies of electronic record
21 CFR Part 58: GLP for Non-clinical Laboratory studies regulation
21 CFR Part 210: cGMP in manufacturing, processing, packing / holding of drug
21 CFR Part 211: cGMP regulations for finished pharmaceuticals
21 CFR Part 820: GMP regulations for Medical devices
Subpart A (General Provisions):
21 CFR Section 211.1 : Scope
21 CFR Section 211.3 : Definitions
Subpart B (Organization and Personnel):
21 CFR Section 211.22 : Responsibilities of Quality unit
21 CFR Section 211.25 : Personnel Qualification
21 CFR Section 211.28 : Personnel Responsibilities
21 CFR Section 211.34 : Consultants
Subpart C (Building and Facilities):
21 CFR Section 211.42 : Design & construction features
21 CFR Section 211.44 : Lighting
21 CFR Section 211.46 : Ventilation, Air filtration, Air heating & cooling
Page 44 of 48 | The Pharma Professionals Interview Guide

21 CFR Section 211.48 : Plumbing


21 CFR Section 211.50 : Sewage and refuse
21 CFR Section 211.52 : Washing and Toilet facilities
21 CFR Section 211.56 : Sanitation
21 CFR Section 211.58 : Maintenance
Subpart D (Equipments):
21 CFR Section 211.63 : Equipment design, size and location
21 CFR Section 211.65 : Equipment construction
21 CFR Section 211.67 : Equipment cleaning and maintenance
21 CFR Section 211.68 : Automatic, Mechanical and Electronic equipment
21 CFR Section 211.72 : Filters
Subpart E (Control of components and drug product container and closures):
21 CFR Section 211.80 : General Requirements
: Receipt and storage of untested components, drug product containers
21 CFR Section 211.82
and closures.
: Testing and approval / rejection of components, drug product
21 CFR Section 211.84
containers and closures.
21 CFR Section 211.86 : Use of approved components, drug product containers and
closures
21 CFR Section 211.87 : Retesting of approved components, drug product containers &
closures
21 CFR Section 211.89 : Rejected components, drug product containers & closures
21 CFR Section 211.94 : Drug product containers and closures
Subpart F (Production and process controls):
21 CFR Section 211.100 : Written procedures and deviations
21 CFR Section 211.101 : Charge-in of components
21 CFR Section 211.103 : Calculation of yield
21 CFR Section 211.105 : Equipment identification
21 CFR Section 211.111 : Time limitation on production
21 CFR Section 211.115 : Re-processing
Subpart G (Packaging and labeling control):
21 CFR Section 211.122 : Materials examination and usage criteria
Page 45 of 48 | The Pharma Professionals Interview Guide

21 CFR Section 211.125 : Labeling issuance


21 CFR Section 211.130 : Packing and labeling operations
21 CFR Section 211.132 :Tamper-evident packing requirements for over-the-counter <OTC>
human drug products
21 CFR Section 211.134 : Drug product inspection
21 CFR Section 211.137 : Expiration dating
Subpart H (Holding and distribution):
21 CFR Section 211.142 : Warehousing procedures
21 CFR Section 211.150 : Distribution procedures
21 CFR Section 211.160 : General Requirements
Subpart I (Laboratory controls):
21 CFR Section 211.165 : Testing and release for distribution
21 CFR Section 211.166 : Stability Testing
21 CFR Section 211.167 : Special testing requirements
21 CFR Section 211.170 : Reserve samples
21 CFR Section 211.173 : Laboratory animals
21 CFR Section 211.176 : Penicillin contamination
Subpart J (Records and Reports):
21 CFR Section 211.180 : General requirements of records and reports
21 CFR Section 211.182 : Equipments cleaning and usage log
21 CFR Section 211.184 : Components, drug product containers, closures and labeling
records
21 CFR Section 211.186 : Master production and control record
21 CFR Section 211.188 : Batch production and control record
21 CFR Section 211.192 : Production records review
21 CFR Section 211.194 : Laboratory records
21 CFR Section 211.196 : Distribution records
21 CFR Section 211.198 : Complaints files
Subpart K (Returned and salvaged drug products):
21 CFR Section 211.204 : Returned drug products
21 CFR Section 211.208 : Drug product salvaging
Page 46 of 48 | The Pharma Professionals Interview Guide

172. What are the different conditions conducted during the forced degradation study?
The following conditions are conducted during forced degradation study:
a) Thermal degradation
b) Photo degradation (Direct sunlight)
c) Acid hydrolysis
d) Base hydrolysis
e) Oxidation
f) Ultra-violet exposure

173. What is clean zone and clean room?


Clean zone: A defined space in which the concentration of air borne particles is controlled to meet a
specified air borne particulate cleanliness class
Clean room: A room in which the concentration of air borne particles is controlled and contains one or
more clean zone.

174. What is As-built clean room (facility)?


A clean room (facility) that is complete and ready for operation, with all services connected and functional,
but without equipment or operational personnel in the facility.

175. What is At-rest clean room (facility)?


A clean room (facility) that is complete and ready for operation, with all services functioning and with
equipment installed and operable or operating, as specified, but without operating personnel in the facility.

176. What is Operational clean room (facility)?


A clean room (facility) in normal operation, with all services functioning and with equipment and personnel,
if applicable, present and performing their normal work functions in the facility. Some other terms used in
the clean rooms:

177. What is unidirectional and non-unidirectional air flow?


Unidirectional air flow: Airflow having generally parallel steam lines, operating in a single direction, and
with uniform velocity over its cross section; previously referred to as “laminar” air flow.
Non-unidirectional air flow: Air flow which does not meet the definition of unidirectional air flow,
previously referred as “Turbulent or Non-Laminar” air flow.
Page 47 of 48 | The Pharma Professionals Interview Guide

178. Describe about the Purified water system and validation?


The purified water system consists of following pre-treatment before final production of purified
water.
 Pre-Treatment
 Reverse Osmosis (RO) Unit
 Electro De-ionization (EDI) System
 Ultra filtration, storage.
Pre-Treatment:
Raw water is stored in raw water tank, then the raw water is chlorinated thereafter. The chlorinated water
is then transferred to the Pressure sand filter to remove the suspended solids and sodium Meta-bisulphite
is dosed in the filtered water to neutralise any trace of residual chlorine present in the filtered water and to
ensure complete de-chlorination. This de-chlorinated is water passed through the softener to reduce the
hardness and then passed through cartridge filter to remove the suspended solids, which may escape from
up-steam units.
Reverse Osmosis (RO):
The filter water is fed to the Reverse Osmosis Plant, and the water passes through three RO units. The RO
is a process for removing dissolved mineral salts, organic molecules and certain other impurities from
water by forcing water under increased pressure to pass through a semi permeable membrane, from that
RO system, water is fed to the EDI system.
Electro De-ionization (EDI) System:
Electro deionization (EDI) is a common sense evolution of conventional ion exchange technology. In EDI,
just as in conventional ion exchange, cat-ions and an-ions in the feed water are exchanged for hydrogen and
hydroxyl ions in the ion exchange resins, producing de-mineralized water. The key operational difference
is that with EDI, the ion exchange resin is regenerated continuously, while with conventional ion exchange,
chemical regeneration is performed intermittently.
Ultra filtration system:
The EDI permeate water passed through the series of seven ultra-filtration membranes and will take care of
bacteria, pyrogens, Total Organic Carbon (TOC) etc. and is collected in Purified water Storage Tank. From
this storage tank the purified water is passed through UV lamp. This water is again circulated and collected
through return loop.
Page 48 of 48 | The Pharma Professionals Interview Guide

Thank you..!
We wish you all best for your bright future...

Please Visit
www.pharmaudyog.com
For latest Job updates, Walk-in interview details
and Vacancy information.
Click Here to Join our WhatsApp Group.
Leave your feedback at [email protected]
Click on icon to catch us on Social media.

You might also like